Home/Filings/4/0001209191-17-009556
4//SEC Filing

EnteroMedics Inc 4

Accession 0001209191-17-009556

CIK 0001371217operating

Filed

Feb 9, 7:00 PM ET

Accepted

Feb 10, 4:37 PM ET

Size

10.7 KB

Accession

0001209191-17-009556

Insider Transaction Report

Form 4
Period: 2017-02-08
Ansari Naqeeb A.
SVP of Sales
Transactions
  • Award

    Stock Option (Right to Buy)

    2017-02-08+93,25093,250 total
    Exercise: $7.12From: 2017-02-08Exp: 2027-02-08Common Stock (93,250 underlying)
Holdings
  • Common Stock

    143
  • Stock Option (Right to Buy)

    Exercise: $91.70From: 2017-01-19Exp: 2026-01-19Common Stock (1,523 underlying)
    1,523
Footnotes (3)
  • [F1]On December 27, 2016, EnteroMedics Inc. effected a 1-for-70 reverse stock split of its issued and outstanding shares of common stock, par value $0.01 per share, resulting in a proportional decrease in the total shares of common stock beneficially owned by the reporting person, all previously reported exercise prices, option grants and similar instruments convertible into common stock were proportionally adjusted to reflect the reverse split.
  • [F2]Vests 25% one-year from the date of grant on the date noted and thereafter in cumulative installments of 1/36th per month.
  • [F3]Vests immediately as to 25% on the date noted and thereafter in cumulative installments of 1/36th per month.

Issuer

EnteroMedics Inc

CIK 0001371217

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001371217

Filing Metadata

Form type
4
Filed
Feb 9, 7:00 PM ET
Accepted
Feb 10, 4:37 PM ET
Size
10.7 KB